Institutional shares held 738 Million
7.09M calls
7.24M puts
Total value of holdings $690B
$6.62B calls
$6.76B puts
Market Cap $901B
950,174,976 Shares Out.
Institutional ownership 77.69%
# of Institutions 3,729


Latest Institutional Activity in LLY

Top Purchases

Q2 2024
Bdf Gestion Shares Held: 30.2K ($28.6M)
Q2 2024
Bank & Trust CO Shares Held: 12.3K ($11.7M)
Q2 2024
Thurston, Springer, Miller, Herd & Titak, Inc. Shares Held: 10.4K ($9.89M)
Q2 2024
Sitrin Capital Management LLC Shares Held: 6.61K ($6.27M)
Q2 2024
Relative Value Partners Group, LLC Shares Held: 8.29K ($7.86M)

Top Sells

Q2 2024
Sg Americas Securities, LLC Shares Held: 27.1K ($25.7M)
Q2 2024
Amf Tjanstepension Ab Shares Held: 155K ($147M)
Q2 2024
Cardinal Capital Management Shares Held: 28.9K ($27.5M)
Q2 2024
Symmetry Partners, LLC Shares Held: 11.3K ($10.7M)
Q2 2024
Legacy Private Trust Co. Shares Held: 8.24K ($7.82M)

About LLY

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.


Insider Transactions at LLY

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
164K Shares
From 34 Insiders
Grant, award, or other acquisition 92K shares
Exercise of conversion of derivative security 71.9K shares
Sell / Disposition
4.16M Shares
From 18 Insiders
Open market or private sale 4.1M shares
Payment of exercise price or tax liability 32.4K shares
Bona fide gift 27.5K shares

Track Institutional and Insider Activities on LLY

Follow ELI LILLY & Co and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LLY shares.

Notify only if

Insider Trading

Get notified when an Eli Lilly & CO insider buys or sells LLY shares.

Notify only if

News

Receive news related to ELI LILLY & Co

Track Activities on LLY